Disclosure received from Dr.Natarajan Arunkumar, Designated Person (SMP) of the Company Under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.3%1-day move

₹76.51

prior close

₹81.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.3-3.3-3.3-1.4+1.3+2.9+1.3+4.6+1.9+4.6-0.7-3.3+37.2+60.8

Up moveDown movePending

AI summary

Dr. Natarajan Arunkumar, a Senior Management Personnel (SMP) of Hannah Joseph Hospital Limited, disclosed acquisition of 26,000 equity shares through three separate on-market purchases on BSE: 2,000 shares on February 5, 2026, 14,000 shares on March 13, 2026, and 10,000 shares on March 30, 2026. Prior to these acquisitions, he held no shares in the company. Post-acquisition, his holding stands at 26,000 shares representing approximately 0.38% of the company's share capital. The disclosure was received by the company on April 1, 2026 and filed with BSE on April 6, 2026 under SEBI's continual disclosure requirements for designated persons.

Likely market impact

This represents fresh buying by a senior management insider, which signals confidence in the company's prospects. The acquisitions are relatively small (0.38% holding), so the direct impact on stock price may be limited, but it does indicate insider optimism.